盆腔炎性疾病与卵巢癌风险:更新版荟萃分析
结果显示盆腔炎性疾病(PID)与卵巢癌风险升高相关(HR 1.18,95%CI 1.13-1.22;I2=41%),各亚组中关联均显著。
要点
- PID与卵巢癌风险升高相关(HR 1.18,95%CI 1.13-1.22)
- 亚洲患者、病例对照研究、侵袭性、交界性及非浆液性卵巢癌亚组关联均显著
- 需未来大型设计良好的研究验证该关联
核心结论
- PID与卵巢癌风险升高相关(HR 1.18,95%CI 1.13-1.22;I2=41%)。
主要发现
- PID与卵巢癌风险升高相关(HR 1.18,95%CI 1.13-1.22;I2=41%)。
- 亚洲患者中PID与卵巢癌关联HR 1.25(95%CI 1.10-1.42),异质性I2=0%-38%。
- 病例对照研究中关联HR 1.15(95%CI 1.08-1.23)。
- 侵袭性卵巢癌HR 1.25(95%CI 1.20-1.30),交界性卵巢癌HR 1.28(95%CI 1.19-1.37)。
- 非浆液性卵巢癌HR 1.15(95%CI 1.07-1.24)。
关键数值与推荐
- PID与卵巢癌风险升高相关(HR 1.18,95%CI 1.13-1.22;I2=41%)。
- 亚洲患者亚组HR 1.25(95%CI 1.10-1.42)。
- 侵袭性卵巢癌亚组HR 1.25(95%CI 1.20-1.30)。
- 交界性卵巢癌亚组HR 1.28(95%CI 1.19-1.37)。
- 非浆液性卵巢癌亚组HR 1.15(95%CI 1.07-1.24)。
临床怎么用
- 对盆腔炎性疾病患者应关注卵巢癌风险,但需结合个体情况评估。
局限性
- 需未来大型、设计良好的研究 corroborate 本研究发现。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Because of conflicting reports regarding the relationship between pelvic inflammatory disease (PID) and ovarian cancer, we performed an updated meta-analysis to investigate the association between PID and the risk of this malignancy. METHODS: Embase, PubMed, and Web of Science were searched up until November 1, 2019. Hazard ratios (HRs), along with 95% confidence intervals (CIs), were calculated to analyse outcomes. RESULTS: We included 16 studies in this meta-analysis. PID was associated with an increased risk of ovarian cancer (HR 1.18, 95% CI 1.13 to 1.22; I2 = 41%). In subgroup analyses according to ethnicity, study design, tumour invasiveness, and type of ovarian cancer, PID was significantly associated with ovarian cancer in all subgroups. The lowest heterogeneity (I2 = 0% to 38%) was observed for associations between PID and ovarian cancer in Asian patients (HR 1.25, 95% CI 1.10 to 1.42), ovarian cancer in case-control studies (HR 1.15, 95% CI 1.08 to 1.23), invasive ovarian cancer (HR 1.25, 95% CI 1.20 to 1.30), borderline ovarian cancer (HR 1.28, 95% CI 1.19 to 1.37), and non-serous ovarian cancer (HR 1.15, 95% CI 1.07 to 1.24). CONCLUSIONS: This updated meta-analysis demonstrated that PID is associated with an increased risk of ovarian cancer. Future large, well-designed studies are necessary to corroborate our findings.
引用
- Piao J, Lee EJ, Lee M, et al. Association between pelvic inflammatory disease and risk of ovarian cancer: An updated meta-analysis. Gynecol Oncol. 2020. PMID: 32037193. doi:10.1016/j.ygyno.2020.02.002
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。